Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
- NAVIGATE ESUS Investigators
- , J. Kunzmann
- , S. Oberndorfer
- , A. Tinchon
Research output: Journal article (peer-reviewed) › Journal article
151
Link opens in a new tab
Citations
(Scopus)